Gestational diabetes mellitus (GDM)
GDM · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Glucose intolerance first recognised in pregnancy, usually after 24 weeks, driven by placental anti-insulin hormones. Raises risk of macrosomia, shoulder dystocia, neonatal hypoglycaemia and later maternal type 2 diabetes.
Red flags
- Fasting glucose >=7.0 mmol/L at diagnosis (likely overt diabetes)
- Fetal macrosomia or polyhydramnios on scan
- Recurrent maternal hypoglycaemia on insulin
- Pre-eclampsia features
- Reduced fetal movements
Assessment
Differential diagnosis
- Pre-existing undiagnosed type 2 diabetes
- Pre-existing type 1 diabetes
- MODY
- Pancreatic/steroid-induced hyperglycaemia
- Stress hyperglycaemia
Investigations
- 75g OGTT at 24-28 weeks (earlier if high risk)
- Fasting and postprandial capillary glucose monitoring
- HbA1c at booking to exclude pre-existing diabetes
- Serial growth ultrasound for fetal size/polyhydramnios
- Urinalysis for ketones/protein
Management
- Confirm diagnosis using local thresholds (NICE: fasting >=5.6 or 2h >=7.8 mmol/L; IADPSG: fasting >=5.1, 1h >=10.0, 2h >=8.5)
- Start dietary/lifestyle advice with dietitian referral and self-monitoring 4x/day
- Set glucose targets: fasting <5.3, 1h post-meal <7.8 or 2h <6.4 mmol/L
- Review glucose diary after 1-2 weeks; if targets unmet add metformin
- Add or switch to insulin if targets still unmet or at presentation with fasting >=7.0 or macrosomia/polyhydramnios
- Arrange serial growth scans every ~4 weeks from 28-36 weeks
- Plan birth: offer delivery by 40+6 weeks (earlier if complications)
- Stop glucose-lowering drugs immediately after delivery
- Check fasting glucose or HbA1c 6-13 weeks postpartum and annually thereafter
- Counsel on lifestyle, ~50% lifetime T2DM risk and future pregnancy screening
Drugs & doses
Metformin 500 mg PO once-twice daily, titrate to max 2-2.5 g/day
Insulin isophane/NPH or basal analogue titrated to fasting target
Insulin aspart with meals titrated to postprandial target
Glibenclamide 2.5-5 mg PO if metformin declined and insulin refused
Disposition
Manage in joint diabetes-antenatal clinic; escalate to obstetrics for growth/liquor abnormalities and plan supervised delivery with neonatal availability.
Complications & pitfalls
- Macrosomia and shoulder dystocia
- Neonatal hypoglycaemia and jaundice
- Pre-eclampsia and polyhydramnios
- Stillbirth
- Progression to type 2 diabetes
Exam pearls
- HbA1c is unreliable late in pregnancy due to red cell turnover; use OGTT and self-monitoring
- Metformin and insulin are both first-line and compatible with breastfeeding
- A fasting glucose above target is the hardest to control with diet alone
- Any woman with prior GDM should be screened early in the next pregnancy
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.